Objective-To assess the current value of necropsy in paediatric cardiology and cardiothoracic surgery and determine its potential impact on clinical practice. Design and setting-Descriptive study of all paediatric cardiac deaths occurring over four years in a tertiary referral centre. Data were obtained from reviewing the hospital files, available necropsy records and specimens, and audit reports. Patients-Paediatric patients with congenital or acquired heart disease, who died of a cardiac cause between January 1992 and July 1995. Inclusion criteria were that the diagnosis of heart disease was made before death, and that patients were managed thereafter medically and/or surgically at the referral centre. The value of necropsy was assessed according to its contribution in establishing the cause of death (confirmed, clarified, precise cause of death uncertain) and the anatomy(simple confirmation or additional information provided). For cases not submitted to necropsy the clinical information relating to the cause of death was assessed and the case assigned as cause of death firm, uncertain, or unknown. Results-One hundred and six deaths were identified (61 males, age at death: one day to 20 years). Seventy occurred early (a month or less) after surgery and were graded as postoperative deaths. The 
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Overall (in days) (31-4)* nplex congenital and January 1992 and July 1995. The necessary We also sought to detailed data had been available during this npact on clinical prac-time from our regular clinico-pathological audit meetings. This period is also representative of the latest era, incorporating the most recent advances such as transoesophageal echocardiography, which has been shown to improve our treated in the depart-diagnostic capability, particularly in postoperathe Royal Brompton tive patients.7 Inclusion criteria were that the or acquired heart dis-diagnosis of heart disease was made before zardiac cause between death, and that patients were managed medically and/or surgically thereafter at our hospital. being reached in most cases before death, a trend confirmed by our study. There is still a great need to establish the precise cause of death and monitor the effects of treatment. Now that complex cardiac surgery and newly developed transcatheter techniques are increasingly used for infants or children with plications"3 have improved both our diagnostic capability and overall outcome. In seven (4%) of the 50 cases, histological findings in the lungs were consistent with pulmonary hypertensive changes, which clinically were thought to have contributed to death. Because cardiopulmonary interactions are so common in children after operative procedures involving the heart, this is an area that should be investigated routinely, whenever a necropsy is performed.
Our data show that necropsy with detailed examination of the heart and lungs remains the ultimate investigation for establishing the precise cause of death in most cases, either by confirming the presumed clinical cause of death or establishing one. The criteria for assessing the value of necropsy, however, must be broader than merely confirming anatomical diagnoses or-in conjunction with the clinical data-establishing the cause of death. Necropsy findings, even when negative, are important in reassuring parents and clinicians that important disease has not been missed. Furthermore, scrutiny of highly skilled, complex operative interventions on hearts at necropsy is essential for idenwtiing possible shortfalls in the attempts of clinicians to produce a perfect result. Necropsy can guide clinicians in optimising some of the technical aspects of newly introduced forms of treatment.
There can be difficulties in obtaining consent for necropsy. '4 There is no euphemism to describe "yet another investigation" to the parents of a child who dies in an intensive care unit, often after major heart surgery. We found that patients who subsequently came to necropsy were more likely to be those who had stayed considerably longer in intensive care after operation. This contrasts with a previous report.' One reason for this difference may be that, in these cases, the clinicians involved were more keen to elucidate the cause of death. In our experience, a simple and clear explanation why a necropsy is being sought, given by a senior member of staff who has already established rapport and understanding with the family, is almost always successful.
We conclude that in paediatric cardiology necropsy continues to provide clinically useful information at a high level. In striving to ensure top-quality medical care, for further improvement in future management, and for increasing our understanding of congenital heart disease, necropsy should continue to be sought actively in all cases.
